As Novo Nordisk’s FDA-approved Wegovy pill sets up a high-stakes comeback, should NVO be back on investors’ radar now?

Earlier this week, Novo Nordisk said the U.S. Food and Drug Administration approved once-daily oral Wegovy, the first GLP-1 pill specifically cleared for chronic weight management and cardiovascular ...

U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.

On December 22, 2025, the U.S. Food and Drug Administration (FDA) formally approved Wegovy® pills, marking a major milestone ...

Weight loss drugs are infiltrating skin clinics providing services like anti-wrinkle injections, sparking concerns the GLP-1 ...

Here are five medical breakthroughs that gave us hope in 2025. In February, a baby with a rare, often fatal genetic disorder ...

While the drugs have become spectacularly popular, their high prices, along with spotty insurance coverage, have left them ...

This year has seen yet more companies leave the Irish stock market, including travel software group Datalex and hotel chain ...

On Monday, the U.S. Food and Drug Administration granted approval for Novo Nordisk's oral version of Wegovy, the first GLP-1 pill aimed at weight loss. This approval is particularly noteworthy as it ...